Notable Analyst Rating Changes 01/19: (BSX) (HMA) (UBS) Upgraded; (CVA) (SYK) (DHI) Downgraded
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
UPGRADES
Bernstein upgrades Boston Scientific (NYSE: BSX) from Market Perform to Outperform, its price target raised $6.50 to $7.
Deutsche Bank lifts Health Management (NYSE: HMA) from Hold to Buy, its price target lowered from $9.50 to $8.50. Click Here for more color.
Morgan Stanley raises UBS AG (NYSE: UBS) from Equal Weight to Overweight.
Canaccord Genuity boosts Garmin Ltd. (Nasdaq: GRMN) from Hold to Buy, its price target raised from $37 to $47.50. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
BofA/Merrill Lynch downgrades Covanta (NYSE: CVA) from Buy to Neutral.
Bernstein lowers Stryker (NYSE: SYK) from Outperform to Market Perform, its price target cut from $57 to $56.
UBS reduces D.R. Horton (NYSE: DHI) from Buy to Neutral. Click Here for more color.
Goldman Sachs drops Walgreen (NYSE: WAG) from Buy to Neutral with a price target of $35 (down from $38). Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
William Blair starts Coach (NYSE: COH) with an Outperform.
Credit Agricole initiates Altria (NYSE: MO) with an Outperform, and $32 price target.
Jefferies assumes Acme Packet (Nasdaq: APKT) at Buy rating and $35 price target. Click Here for more color.
Maxim Group begins Human Genome Sciences (Nasdaq: HGSI) with a Buy, and price target of $14.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Bernstein upgrades Boston Scientific (NYSE: BSX) from Market Perform to Outperform, its price target raised $6.50 to $7.
Deutsche Bank lifts Health Management (NYSE: HMA) from Hold to Buy, its price target lowered from $9.50 to $8.50. Click Here for more color.
Morgan Stanley raises UBS AG (NYSE: UBS) from Equal Weight to Overweight.
Canaccord Genuity boosts Garmin Ltd. (Nasdaq: GRMN) from Hold to Buy, its price target raised from $37 to $47.50. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
BofA/Merrill Lynch downgrades Covanta (NYSE: CVA) from Buy to Neutral.
Bernstein lowers Stryker (NYSE: SYK) from Outperform to Market Perform, its price target cut from $57 to $56.
UBS reduces D.R. Horton (NYSE: DHI) from Buy to Neutral. Click Here for more color.
Goldman Sachs drops Walgreen (NYSE: WAG) from Buy to Neutral with a price target of $35 (down from $38). Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
William Blair starts Coach (NYSE: COH) with an Outperform.
Credit Agricole initiates Altria (NYSE: MO) with an Outperform, and $32 price target.
Jefferies assumes Acme Packet (Nasdaq: APKT) at Buy rating and $35 price target. Click Here for more color.
Maxim Group begins Human Genome Sciences (Nasdaq: HGSI) with a Buy, and price target of $14.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA Securities Starts Mobility Global (MBGL) at Neutral
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Deutsche Bank, UBS, William Blair, Morgan Stanley, Jefferies & Co, Maxim Group, Notable Analyst Rating Changes, Credit Agricole, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
